NAD+ Leadership Position Niagen Bioscience as the global authority on NAD+ with strong clinical backing and a robust patent portfolio to open conversations with healthcare providers, clinics, and wellness brands seeking scientifically validated longevity solutions.

Product Line Synergy Leverage two product lines Tru Niagen and Niagen Plus to cross-sell to both consumer channels and medical/clinical channels, targeting integrative medicine clinics, anti-aging practices, and specialty pharmacies with prescription-grade NAD+ therapies.

Strategic Renaming capitalize on the corporate rebranding to Niagen Bioscience to align outreach with NAD+ expertise, highlighting stability and renewed focus on science-led health solutions when approaching investors, partners, and potential distribution allies.

Expansion & Streamlining Target opportunities related to the strategic divestiture of non-core assets and ongoing operational focus on NAD+ science, offering efficiency-focused solutions, contract manufacturing, or distribution partnerships that complement the core research and product lines.

Global Research Network Engage university labs, research institutes, and clinical trial networks as collaboration or strategic co-development partners, presenting sponsorship or data-sharing opportunities that enhance credibility and expand the reach of Niagen’s NAD+ research programs.